Free Trial

Molina Healthcare (MOH) Stock Forecast & Price Target

Molina Healthcare logo
$155.12 -2.75 (-1.74%)
Closing price 08/1/2025 03:59 PM Eastern
Extended Trading
$154.50 -0.63 (-0.40%)
As of 08/1/2025 07:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Molina Healthcare - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
10
Buy
3

Based on 13 Wall Street analysts who have issued ratings for Molina Healthcare in the last 12 months, the stock has a consensus rating of "Hold." Out of the 13 analysts, 10 have given a hold rating, and 3 have given a buy rating for MOH.

Consensus Price Target

$244.55
57.65% Upside
According to the 13 analysts' twelve-month price targets for Molina Healthcare, the average price target is $244.55. The highest price target for MOH is $414.00, while the lowest price target for MOH is $179.00. The average price target represents a forecasted upside of 57.65% from the current price of $155.12.
Get the Latest News and Ratings for MOH and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Molina Healthcare and its competitors.

Sign Up

MOH Analyst Ratings Over Time

TypeCurrent Forecast
8/3/24 to 8/3/25
1 Month Ago
7/4/24 to 7/4/25
3 Months Ago
5/5/24 to 5/5/25
1 Year Ago
8/4/23 to 8/3/24
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
1 Strong Buy rating(s)
Buy
3 Buy rating(s)
7 Buy rating(s)
6 Buy rating(s)
5 Buy rating(s)
Hold
10 Hold rating(s)
9 Hold rating(s)
9 Hold rating(s)
6 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$244.55$364.21$365.38$374.25
Forecasted Upside57.65% Upside52.07% Upside14.32% Upside6.65% Upside
Consensus Rating
Hold
Hold
Hold
Hold

MOH Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

MOH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Molina Healthcare Stock vs. The Competition

TypeMolina HealthcareMedical CompaniesS&P 500
Consensus Rating Score
2.23
2.81
2.53
Consensus RatingHoldModerate BuyModerate Buy
Predicted Upside57.65% Upside10,407.36% Upside14.55% Upside
News Sentiment Rating
Neutral News

See Recent MOH News
Neutral News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
7/29/2025JPMorgan Chase & Co.
2 of 5 stars
John Stansel
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetNeutral ➝ Neutral$272.00 ➝ $184.00+10.44%
7/25/2025UBS Group
3 of 5 stars
Kevin Caliendo
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetNeutral ➝ Neutral$260.00 ➝ $180.00+9.26%
7/25/2025Barclays
3 of 5 stars
Andrew Mok
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetEqual Weight ➝ Equal Weight$270.00 ➝ $186.00+12.37%
7/25/2025Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
David MacDonald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Hold$335.00 ➝ $180.00+10.57%
7/25/2025Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Sarah James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Neutral$312.00 ➝ $210.00+27.96%
7/25/2025Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Michael Ha
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetNeutral ➝ Neutral$373.00 ➝ $179.00+13.44%
7/23/2025Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Stephen Baxter
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOverweight ➝ Overweight$372.00 ➝ $216.00+16.49%
7/11/2025Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Ann Hynes
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOutperform ➝ Outperform$400.00 ➝ $330.00+49.17%
7/10/2025Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Erin Wright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOverweight ➝ Equal Weight$364.00 ➝ $266.00+12.19%
4/22/2025Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lance Wilkes
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$414.00+37.24%
4/15/2025Baird R W
Subscribe to MarketBeat All Access for the recommendation accuracy rating
M. Ha
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
4/9/2025Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Jason Cassorla
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageNeutral
2/6/2025Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Raj Kumar
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingEqual Weight ➝ Equal Weight$345.00 ➝ $345.00+19.20%
7/29/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetHold ➝ Hold$354.00 ➝ $353.00+6.02%
7/24/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetHold ➝ Hold$354.00 ➝ $297.00+2.86%
7/24/2024TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$412.00 ➝ $351.00+21.57%
3/28/2024Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeNeutral ➝ Underperform$439.00+4.90%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 01:35 AM ET.


Should I Buy Molina Healthcare Stock? MOH Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, July 30, 2025. Please send any questions or comments about these Molina Healthcare pros and cons to contact@marketbeat.com.

Molina Healthcare
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Molina Healthcare, Inc.:

  • The current stock price is around $164.97, which reflects a recent increase of 4.3%, indicating positive market sentiment.
  • Molina Healthcare, Inc. has shown strong revenue growth, with a reported quarterly revenue increase of 15.7% year-over-year, suggesting robust business performance.
  • The company maintains a solid return on equity of 27.72%, which indicates effective management and profitability relative to shareholder equity.
  • Institutional investors hold a significant 98.50% of the company's stock, which often reflects confidence in the company's future prospects.
  • The stock has a relatively low price-to-earnings ratio, suggesting it may be undervalued compared to its earnings, making it an attractive option for value investors.

Molina Healthcare
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Molina Healthcare, Inc. for these reasons:

  • The company recently missed analysts' earnings estimates by a small margin, which could raise concerns about its ability to meet future expectations.
  • Insider selling activity has been noted, with significant shares sold by both the CEO and a director, which may signal a lack of confidence in the stock's short-term performance.
  • The stock has experienced volatility, with a one-year high of $365.23 and a low of $156.36, indicating potential risks associated with price fluctuations.
  • The price-to-earnings-growth ratio is relatively high, which may suggest that the stock is overvalued in relation to its expected growth rate.
  • Despite strong revenue growth, the company's net margin of 2.60% is relatively low, indicating that profitability may be a concern moving forward.

MOH Forecast - Frequently Asked Questions

According to the research reports of 13 Wall Street equities research analysts, the average twelve-month stock price forecast for Molina Healthcare is $244.55, with a high forecast of $414.00 and a low forecast of $179.00.

13 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Molina Healthcare in the last twelve months. There are currently 10 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" MOH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MOH, but not buy additional shares or sell existing shares.

According to analysts, Molina Healthcare's stock has a predicted upside of 57.65% based on their 12-month stock forecasts.

Over the previous 90 days, Molina Healthcare's stock had 1 downgrade by analysts.

Molina Healthcare has been rated by research analysts at Barclays, Cantor Fitzgerald, JPMorgan Chase & Co., Mizuho, Morgan Stanley, Robert W. Baird, Truist Financial, UBS Group, and Wells Fargo & Company in the past 90 days.

Analysts like Molina Healthcare less than other "medical" companies. The consensus rating for Molina Healthcare is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how MOH compares to other companies.


This page (NYSE:MOH) was last updated on 8/3/2025 by MarketBeat.com Staff
From Our Partners